Protein folding, molecule generation and AI-native drug pipelines. The lab bench is going computational.
181 articles
Researchers discovered that chronic stress triggers a gut-microbiota-vitamin-Sting1/Slc9c2 signaling axis that causes sperm count and motility issues. Supplementing with probiotics and vitamins A/E can reverse these fertility defects in animal models.
虎嗅 · 128d ago
Varda Space Industries is scaling its orbital pharmaceutical manufacturing operations. This follows their successful crystallization of the HIV drug Ritonavir in space, proving the viability of microgravity for drug development.
Bloomberg Technology · 129d ago
Varda Space is partnering with United Therapeutics to manufacture medicine molecules in microgravity. This project explores the unique benefits of space-based manufacturing for pharmaceutical development.
Bloomberg Technology · 129d ago
Dr. Liu Cheng discusses the underlying philosophy of cancer treatment and the potential for CAR-T therapy to achieve cancer cures within 20 years.
钛媒体 · 129d ago
BGI Genomics acquires Chongqing Xinyichan to integrate genomics, proteomics, and spatial omics. This multi-dimensional approach forms a composite engine beyond mere sequencing services.
钛媒体 · 129d ago
China's pharma industry scaled up with AI, biotech fusion amid policies like '14th Five-Year Plan'. Revenue stabilized post-fluctuations, exports doubled, shifting to quality-global innovation.
虎嗅 · 136d ago
Traces the evolution history of a single protein via physical AI integration with a century-old Chinese brand. Argues biotech must transcend labs to fuel industrial upgrades.
钛媒体 · 172d ago
A tech CEO leveraged ChatGPT combined with genetic data to create a personalized cancer vaccine, resulting in a 50% tumor reduction. The story also highlights how AI revived his near-death dog, enabling it to chase rabbits in the park again.
量子位 · 188d ago
Temasek CEO Dilhan Pillay Sandrasegara predicts AI will profoundly impact pharma and biotech. He shared this view during a Bloomberg Invest discussion with Lisa Abramowicz.
Bloomberg Technology · 199d ago
China’s technology stocks rebounded alongside AI and biotech shares, while private-fund allocations reached multi-year highs. The article argues that AI remains a long-term market theme, but performance is increasingly differentiated across companies and sectors.
虎嗅 · 42d ago
A Chinese company specializing in laboratory monkey breeding reports a massive profit increase of over 800%. This highlights the growing demand for biological research resources in the biotech sector.
钛媒体 · 62d ago
Zhaoyan New Drug reports a massive 1300% profit increase driven by the high demand and price of laboratory monkeys. The company is a key player in the pharmaceutical research supply chain.
钛媒体 · 63d ago
Mary-Dell Chilton, a foundational figure in biotechnology, passed away at 87. She led the research team that achieved the first successful genetic modification of plants in 1982, revolutionizing global agriculture.
New York Times Technology · 65d ago
A-share listed company JOINN Laboratories saw a massive profit surge driven by the fair value revaluation of its experimental monkey stock, sparking a market trend dubbed 'Monkey Module'. The article analyzes the disconnect between this paper profit and the company's core business performance.
虎嗅 · 65d ago
Hengrui Medicine's subsidiary, Fujian Shengdi Medicine, has received approval to conduct Phase III clinical trials for the HRS9531 injection. The study targets adult patients with obesity combined with knee osteoarthritis.
36氪 · 65d ago
China is experiencing a significant shift in oncology trends, with new annual cases exceeding 5 million. This highlights an urgent need for advanced diagnostic and therapeutic solutions.
钛媒体 · 65d ago
Swiss biotech firm HekeTiss has developed a skin patch using adipose-derived stem cells to treat chronic ulcers. The product has officially entered its first human clinical trial phase.
钛媒体 · 67d ago
This analysis discusses the clinical treatment path for T-cell lymphoma, highlighting the potential underutilization of FDA-approved drugs like Brentuximab Vedotin. It emphasizes the complexity of decision-making in rare cancers where scientific evidence is often limited.
虎嗅 · 68d ago
Guangxi's snake breeding industry is pivoting from food consumption to high-value pharmaceutical and medical applications. This shift aims to build a 50 billion RMB industry through deep processing and drug development.
虎嗅 · 73d ago
Red Sun Pharma has officially terminated its Class 1 chemical drug project for Hepatitis C. The decision follows concerns over high development risks and limited clinical significance.
36氪 · 73d ago
South Korea's biopharmaceutical exports reached $4.5 billion in the first half of the year, marking a 15.3% year-over-year increase. This sector now accounts for 86.5% of the country's total pharmaceutical exports.
36氪 · 73d ago
The innovative drug sector has experienced a sharp rise after a long period of decline, raising questions about whether this marks a long-term market reversal.
钛媒体 · 74d ago
Recent scientific findings suggest that aging is not caused by a single declining metric, but rather by the gradual loss of balance across multiple biological systems.
虎嗅 · 75d ago
Novartis has agreed to acquire British biotech firm Myricx Bio to bolster its oncology pipeline. The deal focuses on experimental drug technology designed to target tumors precisely while sparing healthy cells.
Bloomberg Technology · 75d ago
Bio-Tech Shares expects a 50.6% to 80.39% increase in H1 2026 net profit. The growth is attributed to the expansion of their ruminant and pet health business and improved operational efficiency through digital transformation.
36氪 · 76d ago
CSPC Pharmaceutical's stock saw a significant rise following a new Business Development (BD) partnership. This move signals a potential new wave of innovation and growth in the pharmaceutical sector.
钛媒体 · 78d ago
The article calls for a data-driven re-examination of the Chinese innovative drug industry. It emphasizes the need to assess the underlying industrial foundation beyond surface-level hype.
钛媒体 · 78d ago
The innovative drug sector has recently seen a rebound. This article analyzes the underlying market logic and whether this trend is sustainable given recent industry developments.
虎嗅 · 79d ago
Swiss biotech firm metaLead has developed a novel metal-binding peptide technology. This approach offers high selectivity in removing pathological metals from the body, overcoming limitations of existing therapies.
钛媒体 · 79d ago
Astellas Pharma has reduced the price of its Claudin18.2 targeted therapy, Zolbetuximab, by over 30% in China to compete with emerging local alternatives and secure a spot in the national medical insurance list.
虎嗅 · 81d ago